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Rheumatoid factors (RF)' are defined as autoantibodies binding to the Fc region
ofIgGmolecules, andwere first found in the serum ofrheumatoid arthritis patients
(1, 2) . Increased serum levels ofRF are also detected in other autoimmune diseases
in mouse and man (3-5), and are often produced as monoclonal macrogamma-
globulinemias (6). Similar antibody reactivities may also be detected, however, in
serum from apparently healthy individuals, and they are systematically produced
in secondary, T cell-dependent antibody responses (7-11) or after polyclonal, mito-
genic stimulation ofB cells (12-14) . Several hypotheses have been advanced to ex-
plainRF participation in joint lesion as well as their physiological interest as anti-
bodies enhancing immune responses or antigen clearance (15) .
VanSnick et al . (16-18) have describedthe"spontaneous" production of high titers
of anti-IgG2aRF in the 129/Sv mouse strain and established the IgH-linked control
ofthis phenotype. It was noted, in those studies, that at least one otherlocus partici-
pates in the control of this RF specificity and serum levels . While controlling for
idiotypic binding in the normal serumofdifferent H-2-congenic strains, we observed
marked differences at thelevels ofIgM anti-IgG2a antibodies . Given theassociation
between rheumatoid arthritis and HL-A DR alleles in man, and concerned with
the T cell-dependent selection of antibody repertoires, particularly of those natu-
rally produced in normal animals, we have now formally investigated the role of
H-2 genes in the production ofthis specificity. The results presented hereindemon-
strate that the levels of IgM anti-IgG2a in several mouse strains are essentially con-
trolled by genes linked to IgH and to MHC, particularly the I-E region .
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Materials and Methods
Mice.
￿
C3H/HeJ, C57BL/6, B6.H-2K, C3H.SW, B10.A(4R), B10.MBr, B10.S, B10.HTT,
and DBA/2 mice were bred at the Pasteur Institute . B10.Br, B10.D2, and B10.A(5R) mice
were purchased from OLAC (Bicester, England), and C57BRwas fromTheJackson Labo-
ratory (Bar Harbor, ME). C57BL/6 Ea transgenic mice were a kind gift fromDr. Kishimoto
(Osaka University, Japan) and were bred at the Pasteur Institute .
Antibodies.
￿
The myeloma proteinsMOPC 173 and UPC-10 (bothIgG2a, a) were purified
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from ascitic fluids in a protein A-Sepharose column. The hybridoma F23 .1 (IgG2a, K) (19)
was purified by the same procedure from culture supernatants.
Detection and Quantification of IgM Anti-IgG2a RF.
￿
Polyvinyl plates were coated with the
different monoclonal IgG2a, or a mixture of them (10 kg/ml) in 50 mM phosphate buffer
overnight at 4°C. The plates were then incubated at room temperature for 1 h with PBS
containing 1% gelatin, for 2 h with serial dilutions of individual mouse sera, and for 1 h
with peroxydase-labeled goat anti-mouse 1i chain antibodies (Southern Biotechnologies, Bir-
mingham, AL), with extensive washes between each step. The enzyme reaction was devel-
oped for 20 min, using o-phenylendiamine (Sigma Chemical Co., St. Louis, MO) as a sub-
strate, and quantified photometrically in a Multiscan (Flow Laboratories, Irvine, UK) at
a 450-nm wavelength. In every plate, a monoclonal IgM anti-IgG2a was titrated and used
as standard. All the data are expressed as equivalents (in Ag/ml) of the mAb.
Typing ofIgCHAllotype.
￿
The IgM and IgG2a allotypes were identified by a solid phase
assay in ELISA using the following antiallotypic mAbs: anti-Ig66 MB.86 (20); anti-Iglb G12-
47.30 (a kind gift from Dr. P Vieira, Cologne University, FRG); anti-Ig6a RS3.1 (21); and
anti-Igla Igla (8.3) (22).
Polyvinyl plates were coated with the different antiallotypic mAbs at 10,ug/ml. After satu-
ration and incubation with serial dilutions of individual sera, they were incubated with the
same biotin-labeled mAbs used for the coating, followed by a 1-h incubation with peroxydase-
conjugated avidin (Milles, Bethesda, MD). All other stepsin the ELISA technique were iden-
tical to those above.
TypingofH-2.
￿
The H-2 haplotype was typed in a solid phase RIA with fixed white blood
cells. Briefly, mice were bled in heparinized tubes and the whitecells enriched by centrifuga-
tion in a Ficoll. A serial titration of the enriched population was fixed with glutaraldehyde
to polystyrene plates, and incubated with '251-labeled anti-I-Elk (14.4.4) (23), or anti-I-Al
(25.9.175)(24) antibodies. After extensive washing, the radioactivity was measured in a gamma
counter. Alternatively, white blood cells or spleen cells were incubated with the same anti-
bodies labeled with fluorochromes and analyzed in a FACScan (Becton Dickinson & Co.,
Mountain View, CA).
Statistical Analysis.
￿
Typing of individual animals for IgM anti-IgG2a RF expression, in
the progenies ofthe crosses analyzed, was done as follows. All animals in the cross, irrespec-
tive of the expression of other segregating markers, were distributed in classes defined by
the concentration ofIgM anti-IgG2a serum antibodies. In cases where this trait is segregating,
two roughly gaussian populations become evident in the distribution, with a cutting point
at N3-5 jig/ml equivalents, allowing for the classification of high and low expression, regard-
less of other groupings within each of these populations (see below).
Results
Serum Levels ofIgMAnti-IgG2a RF in C3HIHej, C57BL/6, respective Fr Hybrids, and
H-2 Congenic Strains. In the course ofunrelated experiments, we noted marked differ-
ences in the titers of IgM antibodies binding to ELISA plates coated with IgG2a
preparations that could be detected in the sera from various mouse strains. We have
ascertained: (a) the strain dependence ofthis phenomenon, by the comparable levels
detected in many individual sera within a given strain; and (b) the RF specificity
of such IgMs, first, by finding comparative binding ofthe same sera to threedifferent
IgG2a mAbs or mixtures thereof, and second, by the complete removal of serum
IgM binding to all three IgG2a mAbs by immunoabsorption of the serum on a
Sepharose column coupled with one of them only (data not shown). We proceeded,
therefore, to quantitate such RF in the serum of a variety of mouse strains, and
chose to analyze in detail C3H/HeJ (C3H) and C57BL/6 (B6) as prototypes ofhigh
and low expressors, respectively (Fig. 1). Not only were the differences between these1 .5 1
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FIGURE 1. C3H/Hej (A) or
C57BIJ6 (B) individual sera
were titrated into plates coated
with a mixture of MOPC-173,
UPC-10, and F23.1 antibodies.
Bound IgM was detected with
p chain-specific, peroxydase-
labeled antibodies. Each point
represents the mean OD ofdup-
licate determinations.
two strains readily detectable, but also, we had available the appropriate H-2 con-
genic and RI lines, as well as intra-H-2 recombinants in b/k haplotypes.
The finding of high RF titers in normal CM mice is reminiscent of Van Snick's
observations (25). We have also confirmed the age dependence of the serum titers
and the prevalence of IgM RF in younger animals, in contrast to the predominance
of IgA RF in animals older than 4-6 mo. Because background genes appear to have
a determinant effect on the total levels of IgA production, very different in C3H
and B6 strains, we will only consider here IgM RF in relatively younganimals (8-16
wk), where levels of total serum IgM are comparable, although IgA RF were also
quantitated in all experiments. Even if RF titers continue to increase with age, am-
plifying the strain differences, these are already sufficiently marked at that age to
allow for unambiguous typing.
The serum IgM RF concentrations might be in part controlled by MHC-linked
genes, as suggested by the study of MHC-congenic animals to the prototype strains.
As shown in Fig. 2, B6.H-2K mice type as C3H, and C3H.SW type as B6. Fig.
2 also shows that F, hybrids between high and low expressors of RF are all low ex-
pressors, demonstrating that in these cases the trait low expressor phenotype is dom-
inant, as it has already been shownin several independent progenies of 129/Sv strain
crosses (17, 18). In addition, (B6.H-2K x C3H)F, hybrids were also found to be
low expressed. These results are already suggestive that H-2-linked and unlinked
genes both contribute to RF phenotype.
Segregation Analyses ofBackcross Progenies between High and Low IgM Anti-IgG2A RF
Expressors: IgH- and H-2-linked Control. The suggestion of MHC-linked control
provided by the congenic strains was evaluated by conventional genetic analyses in
progenies of backcrosses between the prototype strains, segregating for H-2, IgH-
allotype, and RF phenotype. Backcrossing of(CM x B6)Ft mice to high expressor
CM mice resulted in progenies that segregated for serum RF concentrations, in
a pattern compatible with a genetic control by one or two unlinked loci (numbers
of low and high expressors being 26 and 41, respectively).
Typing of these progenies for IgH haplotypes shows clear linkage of RF levels to1828
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Different H-2-congenic mouse strains and F1 hybrids. Each point corresponds to
an individual mouse. Mice were tested between 8 and 14 wk of age.
100"
T_
-
--I
-.
￿
1
86.H-2K
￿
C57BI/6 C3H/HeJ C3H.SW
H-2 kk kb kk kb
IgCH 11 )) jb Jb
Cross (C3H/HeJxC57BI/6)xC3H/HeJ
He 000
￿
00 9 - 0 -6
CS?BI/6xB6.H-2K C3HIIieJxC578116 C3HiHeJxC3H.SW C3H/HeJxB6 .H-2K
FIGURE 3.
￿
(C3H/HeJ x C57BL/6)FI x C3H/
HeJ mice distributed as to their H-2 and IgH
00
￿
haplotypes. Each point corresponds to an in-
0
￿
dividual mouse and represents the mean of six
e
￿
different determinations using three different
IgG2aantibodies (see Materials andMethods).
0*0
￿
Mice were tested at 12 wk of age.
" ":"
0.: SUPEREIRA AND COUTINHO
￿
1829
the IgH locus. Thus, all high expressors are IgHi homozygous (Fig. 3 and Table
I). Furthermore, a closer scrutiny of the quantitative levels of RF expression, to-
gether with H-2 typing ofthese mice, reveals that high and low expressors are both
clustered in two subgroups showing a precise linkage to H-2: H-2K homozygocity
determineshigher levels ofexpression inboth IgH allotypegroups (Fig. 3 and Table
II). It is also interesting to note that H-2 heterozygous backcrossesto C3H are high
RF expressed in contrast to Fl animals. This indicates that there are assortments
ofC3H and B6 genomes that are compatible with high RF expression even in H-2
heterozygous animals.
Fig. 3 also shows that in animals carrying IgH or H-2 haplotype combinations
that are not those of prototype high or low expressors, RF seem to fall into, yet,
otherclusterings. This could suggest theexistence ofa thirdlocus controlling quan-
titatively the levels of RF expression. With too few animals analyzed here for this
contention, we dare to advance this suggestion because of published data by Van
Snick (17) concerning F2 and backcrosses of 129/Sv and C57BL/6 strains. In such
crosses, where the segregating H-2 haplotypes could be expected to have minor or
noeffects, clusteringofanimalswithin IgH-defined groups was also observed. More
specific information concerning this issue can be obtained by the analysis ofavail-
able F2 recombinant inbred strains between C3H and B6, as well as their crosses
to either parental strain, which might provide a definite conclusion.
TABLE I
IgCH Allotype-linked Gene Control ofRF Expression in
FI(C3H x B6) x C3HProgenies
Number of mice
IgH
￿
Number
￿
with >3 ug/ml
haplotype
￿
of mice
￿
IgM anti-IgG2a
￿
t' p
jj
￿
32
￿
26
jb
￿
35
￿
0
￿
50.1
￿
<5 x 10-4
Animals with >3 ug/ml IgM anti-IgG2a RF were considered as high expres-
sors (see Materials and Methods).
' Considering all the animals. If only high expressor animals are considered,
the differences are still significative (t = 2 .47 p < 0.05).
TABLE II
H-2-linked Gene Control of the RF levels in
Fi(C3H x B6) x C3H Progenies Homozygous for IgCHJ Haplotype
Number of mice
H-2
￿
Number
￿
with >3 jig/ml
￿
IgM anti-IgG2a
haplotype
￿
of mice
￿
IgM anti-IgG2a
￿
titers
￿
t' p
+ SD
kk
￿
15
￿
15
￿
17.7 + 8.8
￿
3.79 <0.01
kb
￿
16
￿
11
￿
7.5 + 6
Animals with >3 jig/nil IgM anti-IgG2a RF were considered as high expres-
sors (see Materials and Methods).
' Considering all the animals. If only high expressor animals are considered,
the differences are still significative (t = 2.47 p < 0.05).1830
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Given the apparent complexity ofthis genetic control, H-2 linkage could be best
addressedinbackcrosses where alltheother lociare fixed, namely between twoH-2-
congenic strains. This experiment would also give an internal control for the dis-
criminatory ranges ofthe assay detecting RE Fig. 4shows theresultsofsuch crosses
between (C3H/HeJ x C3HSW)FI back to C3H/HeJ, where all but one H-2k homo-
zygous mouse have high levels of anti-IgG2a RF, while, again, all but one H-2lb
heterozygous mouse arelow expressor. Evenincluding those twoexceptionalanimals,
which might reflect an experimental error, thelinkagebetween high RF expression
and H-2 in these backcrosses is statistically significant (p < 0.01).
I-E Control ofIgMAnti-IgG2a RFProduction.
￿
We next set out to investigate which
subregion ofthe H-2 complex is involved in the regulation ofthe serum levels of
IgM anti-IgG2a RE Table III shows the results obtained with different intra-H-2-
recombinant mice, congenic to C57BL.10. As can be seen, mice ofthe B10.A(4R)
strain are low expressors (like B10 and B6), while B10.Br, B10.MBR, and B10.A(5R)
are high expressors. Thesedatasuggest thatthe expression ofI-E, orofa geneclosely
linked to it, is sufficient and necessary fortheexpression ofhigh levels ofIgM anti-
IgG2aRF intheC57BLbackground. The sameconclusionis supportedby theanalysis
ofintra-H-2-recombinant inbred strains between H-28 (I-E nonexpressor) and H-2k
(I-E expressor) haplotypes. As can be also seen in Table III, BIOS (I-E-) behaves
as a low expressor, while B10.HTT (I-E') appears as a high expressor. Furthermore,
another I-E+ H-2-congenic strain with B10, namely B10.D2 carrying the d haplo-
type, also types as high RF expressor.
To ascertain whether the serum levels of IgM anti-IgG2a are directly controlled
by the expression ofthe I-E molecule, orby some other genes closely linked to the
I-E region, we analyzed C57BL/6 mice carrying the I-Ed transgene (26). As shown
in Fig. 5, these mice express increasing levels of seric IgM anti-IgG2a with age in
contrast to their nontransgeniclittermates, whichexpress undetectable levels ofanti-
IgG2a IgM. These results demonstrate that the expression of the I-E molecule is
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TABLE III
RF Expression in Different Intra-H-2-recombinant Strains ofMice
' Only a pooled serum from five animals was tested.
i
Transgen + -
￿
+ -
FIGURE 5.
￿
Expression of IgM
anti-IgG2a RF in C57BL/6
(E9) transgenic mice and their
littermates at 7wk (A) or 14 wk
(B) of age. Each point corre-
sponds to an individual mouse.
sufficient and necessary for the production ofhigh levels ofIgM anti-IgG2a RF in
the C57BL/6 strain.
Discussion
The production of RF able to bind autologous IgG in certain specific pathogen-
freemouse colonies has been shown to be strain specific in quantitative andqualita-
tiveterms, and appearsto becontrolled by both geneticandenvironmental factors.
Those RF belong to the IgMclass in young animals and switch, progressively with
age, to IgA (16, 25). By crossing 129/Sv mice, as aprototype ofhigh RF expressors,
with different nonexpressor Fl hybrid mice, Van Snick et al. (17, 18) have shown
the dominance ofthe low RF phenotype and a linkage tothe IgCH allotype or to
MHC genes.
We have now analyzed the genetic control of spontaneous RF production using
C3H as a high expressor prototype strain. Our data confirm a major role for IgH
A B
Strain K I-A
H-2
I-A I-E I-E D
Animals with
>3 pg/ml
IgM anti-IgG2a IgM anti-IgG2a
t SE (ag/ml)
B10.Cr b b b b - b 0/5 <1
MO.Br k k k k k k 8/10 7 .2 t 1 .46
B10.MBr b k k k k q 4/4 9 t 1 .3
B10.A(4R) k k k k - b 0/5 <1
B10.A(5R) b b b b k k -' 9'
B10.S s s s s - s 0/5 <1
B10.HTT s s s s k k 5/5 18 1 3.6
B10.D2 d d d d d d 6/6 7.6 1 0.911832
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allotype-linked genes in the RF expressor phenotype, show a clear control by the
H-2 complex and, more precisely, map it to the I-E locus. Consideringthis multiple
genetic control of RF production, several important points should be discussed.
First, we note the finding that Fl hybrids between high and low RF expressors
type as low expressors, that is, the low RF phenotype is dominant. This is true for
all six F1 hybrids that we have tested as well as for all crosses previously described
by Van Snick (17, 18), using the 129/Sv strain as high expressor and a number of
low expressor strains. Fl low expressor phenotype is then a major characteristic of
the genetic control of RF production. Thus, heterozygocytes of H-2 only, e.g., (B6
x B6.H-2K)F1 or (C3H x C.SW)F1, of non-H-2 genes only, e.g., (B6.H-2K x
C3H)Fl or (BALB/c x B6)F1 (not shown) are sufficient to suppress RF expression.
This, however, does not seem to reflect suppressive mechanisms of the type con-
trolled by conventional Is genes. Thus, H-2k " b heterozygous can actually be high
expressors, as shown here with (C3H x B6)Fl x C3H backcrosses, or by crossing
(C3H x B6)Rl lines carrying H-2k with B6 (unpublished observations). It would
seem, therefore, that if at all resulting from suppressive mechanisms (see below),
low RF expression would be the consequence of interactions between the products
of H-2 alleles and those of other non-MHC polymorphic genes.
Second, when low expressor Fl hybrids are backcrossed to the high expressor pa-
rental strain, a clear linkage to the IgH locus is shown. In our data, this is even
more striking because both IgH haplotypes studied appear to be equally compe-
tent when placed in the appropriate background (e.g., the j allotype in C3H and
the b allotype in B6.H-2K). This suggests that the control of RF production by
IgH-linked genes does not reflect the absence or presence of a particular set of VH
genes, but rather, the regulation of the expression of those genes, more particularly
the selection of the B cells producing RR Alternatively, since we deal here with the
production of autoantibodies, IgH linkage could reflect polymorphism of the au-
toantigen (IgG2a C regions).
The role of H-2-linked genes is more complex to discuss. The analysis of intra-
H-2-recombinant strains in the B10 background andof the C57BL/6-transgenic mice
carrying the I-E« gene demonstrates that the expression of the I-E molecule is
sufficient and necessary for the high RF phenotype in that background. This link-
age supports the notion that specific T cells are required in the spontaneous produc-
tion of RF (27), as it has been shown in the course of secondaryresponses to protein
antigens (7-10), and suggests that low RF production in B6 is not the result of sup-
pressive mechanisms. I-E expression, regardless of its "fine specificity," seems here
to be essential, since all four E alleles tested (ofthe k, b, s, and d haplotypes) ensure
high RF expression. The situation appears quite different, however, from the Ir gene
effects (helper or suppressor), be those resulting from either positive or negative
selection of T cell repertoires. Thus, if I-E were functioning in positive selection
of some T cell specificities, in agreement with the "responder" phenotype of the pa-
rental strains, we would expect a "high responder" phenotype in Fl hybrid animals
(27), and this is not the case. Conversely, if I-E expression would result in clonal
deletion of"suppressive" T cells, we would again expect dominant high RF expres-
sion. Finally, if I-E functions by positive selection of suppressors cells, as suggested
by the F1 phenotype, we would expect for the parental strains an expression of RFPEREIRA AND COUTINHO
￿
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that is the opposite ofwhat is observed. One possible explanation invokes quantita-
tive differences in the cellular density of I-E expression, which in a (k x b)F1
should only be half of the homozygous or transgenic animals. Another possibility
could postulate the involvement of other MHC (but not I-E) genes in a complex
control of this phenotype, which, not unlikely, may involve various clones of cooper-
ative and regulatory cells.
These considerations on H-2 controls should nowadays be taken together with
putative polymorphisms in genes encoding (self) proteins that may associate with
MHC molecules and determine negative or positive selection of T cell repertoires
(28-33). As seen above, the structural antigen itself (C regions of IgG2a) may be
one of these. Any other background gene, however, could result in similar effects.
Finally, TCR genes are likely to be implicated in the regulation of this phenotype
(27), which is then the result of complex selective processes that involve the prod-
ucts of several loci. Alleles at each of these loci may be either permissive or "sup-
pressive" in thecontext ofdifferent"background" geneticconstitution. It is, therefore,
inappropriate to conclude on the participation or noninvolvement of a particular
locus (e.g., Mls-1, TCR-0, etc.) by the typing of independent strains, although we
have much data already available.
In summary, both the IgH-linked and I-E gene, which undoubtedly control RF
expression, provide forhigh or low expression phenotypes depending upon homo-
or heterozygocity, the allelic context ofthe otherlocus, and other background genes.
This complex genetic control suggests that the spontaneous production of high RF
levels requires multiple molecular and cellular interactions between different lym-
phocyte subsets, the repertoires of which may have had their selection determined
by those loci. Given the close association between allelic forms of DR and rheuma-
toid arthritis in humans (34), our results indicate that further efforts in the charac-
terization of those mechanisms and interactions are urgent.
Summary
Theconcentration ofserum IgM moleculesbindingto IgG2a(rheumatoid factor
[RF]) in solidphase assays is 10-100-fold higher in normal, unmanipulatedC3H/HeJ
(H-2k) than in C57BL/6 (H-2b) mice. Analysis of MHC-congenic mice with the
prototype strains show that C3H SW (H-2b) are low, and B6.H-2k are high RF ex-
pressor strains, respectively. Furthermore, segregation of RF phenotypes in proge-
nies from backcrosses to C3H/HeJ of (C3H/HeJ x C57BL/6)Fl hybrid mice shows
MHC- and IgH-linked controls. RF phenotypes also segregate as ifthey are MHC
linked in crossesbetween H-2-congenic strains (C3H/HeJ and C3HSW). The study
of intra-H-2 (k/b and k/s) recombinant mice suggested that RF phenotype control
is linked to the I-E region. This was confirmed by the typing of C57BL/6 mice ex-
pressing a transgenic Ea chain, and thus, I-E+, which, in contrast to nontransgenic
littermates, are high expressors of RE
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